Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0

Copyright information:Taken from "Increased fluoroquinolone resistance with time in from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location"http://www.biomedcentral.com/1471-2334/8/4BMC Infectious Diseases 2008;8():4-4.Published online 15 J...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Boyd, Lauren Becnel, Atmar, Robert L, Randall, Graham L, Hamill, Richard J, Steffen, David, Zechiedrich, Lynn
Format: Bild
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Boyd, Lauren Becnel
Atmar, Robert L
Randall, Graham L
Hamill, Richard J
Steffen, David
Zechiedrich, Lynn
description Copyright information:Taken from "Increased fluoroquinolone resistance with time in from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location"http://www.biomedcentral.com/1471-2334/8/4BMC Infectious Diseases 2008;8():4-4.Published online 15 Jan 2008PMCID:PMC2258293.loxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002.
doi_str_mv 10.6084/m9.figshare.74138
format Image
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_74138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_74138</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_741383</originalsourceid><addsrcrecordid>eNqdj71OAzEQhK-hQMAD0O0DJIetRPmpoyDo6a2Vb323ku097LUgj8LbckHwAjQzI81M8XXdozX9zhy2T-nYBx7rhIX6_dZuDrfd12v2hbDSACE2KfLeOEuUTFCoclXMnuCDdQLlRMAZQpEEdr8yxsCMypS1AiogRCwjgZeW9QKT1JkVI-DSQmjZK0sGCeBb1FYIKiutAMdFKn0uKQ8QxeN1tzb33U3AWOnh1-86-3x-O72sB1T0y9XNhROWi7PGXfFcOro_PPeDt_nP5xvPLGQb</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0</title><source>DataCite</source><creator>Boyd, Lauren Becnel ; Atmar, Robert L ; Randall, Graham L ; Hamill, Richard J ; Steffen, David ; Zechiedrich, Lynn</creator><creatorcontrib>Boyd, Lauren Becnel ; Atmar, Robert L ; Randall, Graham L ; Hamill, Richard J ; Steffen, David ; Zechiedrich, Lynn</creatorcontrib><description>Copyright information:Taken from "Increased fluoroquinolone resistance with time in from &gt;17,000 patients at a large county hospital as a function of culture site, age, sex, and location"http://www.biomedcentral.com/1471-2334/8/4BMC Infectious Diseases 2008;8():4-4.Published online 15 Jan 2008PMCID:PMC2258293.loxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002.</description><identifier>DOI: 10.6084/m9.figshare.74138</identifier><language>eng</language><publisher>figshare</publisher><subject>Medicine</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>777,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.74138$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Boyd, Lauren Becnel</creatorcontrib><creatorcontrib>Atmar, Robert L</creatorcontrib><creatorcontrib>Randall, Graham L</creatorcontrib><creatorcontrib>Hamill, Richard J</creatorcontrib><creatorcontrib>Steffen, David</creatorcontrib><creatorcontrib>Zechiedrich, Lynn</creatorcontrib><title>Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0</title><description>Copyright information:Taken from "Increased fluoroquinolone resistance with time in from &gt;17,000 patients at a large county hospital as a function of culture site, age, sex, and location"http://www.biomedcentral.com/1471-2334/8/4BMC Infectious Diseases 2008;8():4-4.Published online 15 Jan 2008PMCID:PMC2258293.loxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002.</description><subject>Medicine</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2011</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqdj71OAzEQhK-hQMAD0O0DJIetRPmpoyDo6a2Vb323ku097LUgj8LbckHwAjQzI81M8XXdozX9zhy2T-nYBx7rhIX6_dZuDrfd12v2hbDSACE2KfLeOEuUTFCoclXMnuCDdQLlRMAZQpEEdr8yxsCMypS1AiogRCwjgZeW9QKT1JkVI-DSQmjZK0sGCeBb1FYIKiutAMdFKn0uKQ8QxeN1tzb33U3AWOnh1-86-3x-O72sB1T0y9XNhROWi7PGXfFcOro_PPeDt_nP5xvPLGQb</recordid><startdate>20111231</startdate><enddate>20111231</enddate><creator>Boyd, Lauren Becnel</creator><creator>Atmar, Robert L</creator><creator>Randall, Graham L</creator><creator>Hamill, Richard J</creator><creator>Steffen, David</creator><creator>Zechiedrich, Lynn</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20111231</creationdate><title>Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0</title><author>Boyd, Lauren Becnel ; Atmar, Robert L ; Randall, Graham L ; Hamill, Richard J ; Steffen, David ; Zechiedrich, Lynn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_741383</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>Boyd, Lauren Becnel</creatorcontrib><creatorcontrib>Atmar, Robert L</creatorcontrib><creatorcontrib>Randall, Graham L</creatorcontrib><creatorcontrib>Hamill, Richard J</creatorcontrib><creatorcontrib>Steffen, David</creatorcontrib><creatorcontrib>Zechiedrich, Lynn</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Boyd, Lauren Becnel</au><au>Atmar, Robert L</au><au>Randall, Graham L</au><au>Hamill, Richard J</au><au>Steffen, David</au><au>Zechiedrich, Lynn</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0</title><date>2011-12-31</date><risdate>2011</risdate><abstract>Copyright information:Taken from "Increased fluoroquinolone resistance with time in from &gt;17,000 patients at a large county hospital as a function of culture site, age, sex, and location"http://www.biomedcentral.com/1471-2334/8/4BMC Infectious Diseases 2008;8():4-4.Published online 15 Jan 2008PMCID:PMC2258293.loxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.74138</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.74138
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_74138
source DataCite
subjects Medicine
title Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Boyd,%20Lauren%20Becnel&rft.date=2011-12-31&rft_id=info:doi/10.6084/m9.figshare.74138&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_74138%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true